Pulmonology
From the Journals
COPD: Large-scale study suggests protective role for vitamin D
“Our findings imply that vitamin D might play a role in progression of COPD.”
News from the FDA/CDC
Pneumococcal vaccine label adds injection-site risk
Reports of injection-site necrosis emerged after the vaccine had been approved by the FDA and was administered to a large, diverse, real-world...
News from the FDA/CDC
FDA approves RSV monoclonal antibody for all infants
The long-acting antibody is given as a single intramuscular injection.
Latest News
LAMA-LABA surpasses corticosteroid combination as COPD therapy
Large matched cohort study suggests stronger safety and effectiveness outcomes with LAMA-LABA inhalers vs. ICS-LABA inhalers.
From the Journals
Spirometry predicts mortality in type 2 diabetes
PRISm occurs in approximately 10% of the general population and has been identified as a predictor of adverse health outcomes.
Feature
Parsing the split-decision victory for biologics in COPD
It’s tough to keep up with the proliferation of monoclonal antibodies.
Feature
Geriatric care principles should apply to ICUs as well
Physical frailty, disabilities, and multimorbidities increase the risk for adverse outcomes among elderly patients with obstructive airways...
From the Journals
Pulmonary embolism confers higher mortality long term
The most frequent causes of death were cancer, pulmonary embolism, infections, and cardiovascular events.
From the Journals
Comorbid respiratory disease key predictor of NTM-PD
Overall, comorbid respiratory disease was significantly associated with an increased risk of NTM-PD.
News from the FDA/CDC
CDC signs off on RSV vaccine for older adults
The vote recommending shared decision making about the vaccine, instead of a routine vaccination recommended for all, “is a weaker recommendation...